Treatment default and death among tuberculosis patients in Hunan, China

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 4, 2010, Pages 281-287

  Abuaku, Benjamin ^a   Tan, Hongzhuan ^a   Li, Xingli ^a   Chen, Mengshi ^a   Huang, Xin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CHINA; DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SPUTUM SMEAR; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; CHINA; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SEX FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; URBAN POPULATION; YOUNG ADULT;

EID: 77949450394     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903493723     Document Type: Article

References (23)

1. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3 rd ed. WHO/CDS/TB 2003.313. Geneva: World Health Organization; 2003.
2. World Health Organization. The global plan to stop TB, 2006-2015. Geneva: World Health Organization; 2006.
3. World Health Organization. WHO report 2009. Global tuberculosis control: epidemiology, strategy, financing. Geneva: World Health Organization; 2009.
4. World Health Organization. WHO Report 2007. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2007.
5. Chan ED, Iseman MD. Current medical treatment for tuberculosis. Br Med J 2002;325:1282-1286
6. Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health 2005; 5:14.
7. Vasankari T, Holmström P, Ollegren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health 2007; 7:291.
8. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002;6:780-788
9. Chiang CY, Slama K, Enarson DA. Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis 2007;11: 258-262
10. World Health Organization and Ministry of Health China. WHO-AIMS report on mental health system in the Hunan Province of the People's Republic of China. Changsha: World Health Organization; 2006.
11. United Nations Economic and Social Commission for Asia and the Pacific. Hunan. Available at: http://www.unescap.org/ esid/psis/population/database/ chinadata/hunan.htm (accessed November 21, 2007).
12. World Health Organization. WHO report 2002. Global tuberculosis control: surveillance, planning, financing. WHO/ CDS/TB 2002.295. Geneva: World Health Organization; 2002.
13. Antoine D, French CE, Jones J, Watson JM. Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001. J Epidemiol Community Health 2007;61:302-307
14. Kharsany AB, Connolly C, Olowolagba A, Abdool Karim SS, Abdool Karim Q. TB treatment outcomes following directlyobserved treatment at an urban outpatient specialist TB facility in South Africa. Trop Doct 2006;36:23-25
15. Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998;2:372-377
16. Chan-Yeung M, Noertjojo K, Tan J, Chan SL, Tam CM. Prevalence and predictors of default from tuberculosis treatment in Hong Kong. Hong Kong Med J 2003;9: 263-268
17. World Health Organization Regional Office for the Western Pacific. Smoking statistics. Available at: http://www.wpro. who.int/media-centre/fact- sheets/fs-20020528.htm (accessed June 18, 2009).
18. Anunnatsiri S, Chetchotisakd P, Wanke C. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health 2005;36:323-330
19. Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasicher V, Shulgina M, et al. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. Int J Tuberc Lung Dis 2003;7: 1045-1051
20. Becx-Bleumink M, Djamaluddin S, Loprang F, de Soldenhoff R, Wibowo H, Aryono M. High cure rates in smear-positive tuberculosis patients using ambulatory treatment with once-weekly supervision during the intensive phase in Sulawesi, Republic of Indonesia. Int J Tuberc Lung Dis 1999;3:1066-1072
21. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367:938-940
22. Abubakar I, Crofts JP, Gelb D, Story A, Andrews N, Watson JM. Investigating urban-rural disparities in tuberculosis treatment outcome in England and Wales. Epidemiol Infect 2008;136:122-127
23. Maria de Fatima PM, Ricardo Arraes de Alencar X, Norma LS, Vierira de Souza W, Andrea TD, Odimariles Maria SD, et al. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saúde Pública 2007;23:1573-1582